E. Feldman
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
-
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 13
- Acute Myeloid Leukemia Research 11
- Chronic Myeloid Leukemia Treatments 4
- Multiple Myeloma Research and Treatments 3
-
- Histone Deacetylase Inhibitors Research 3
- Retinoids in leukemia and cellular processes 2
- RNA Interference and Gene Delivery 2
- Co-authors
- Karen Seiter (3 shared papers)Joseph Bertino (1 shared paper)Ellin Berman (1 shared paper)P. Maslak (1 shared paper)David A. Scheinberg (1 shared paper)David W. Golde (1 shared paper)Toby Gee (1 shared paper)Abraham Mittelman (2 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)Bone Marrow Transplantation (1 paper)Cancer Investigation (1 paper)International Journal of Oncology (1 paper)Leukemia Research (1 paper)
- Partner nations
- United StatesIndia
In The Last Decade
E. Feldman
17 papers receiving 160 citations
Peers
Comparison fields: 5 of 26
- Hematology 103
- Genetics 39
- Public Health, Environmental and Occupational Health 58
- Oncology 41
- Pathology and Forensic Medicine 22
Countries citing papers authored by E. Feldman
This map shows the geographic impact of E. Feldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Feldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Feldman more than expected).
Fields of papers citing papers by E. Feldman
This network shows the impact of papers produced by E. Feldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Feldman. The network helps show where E. Feldman may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Feldman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 48 | |
| 2 | 2005 | 29 | |
| 3 | High-dose, potentially myeloablative chemotherapy and autologous bone marrow transplantation for patients with advanced Hodgkin's disease. | 1989 | 25 |
| 4 | 2000 | 15 | |
| 5 | 1999 | 9 | |
| 6 | 2010 | 6 | |
| 7 | 2011 | 5 | |
| 8 | 2011 | 5 | |
| 9 | 2005 | 4 | |
| 10 | Phase I-II trial of high dose Ara-C, carboplatinum, etoposide and steroids in patients with refractory or relapsed lymphomas. | 1994 | 4 |
| 11 | 2005 | 3 | |
| 12 | 2010 | 3 | |
| 13 | 1999 | 2 | |
| 14 | 2011 | 2 | |
| 15 | 1990 | 1 | |
| 16 | 1992 | 1 | |
| 17 | 2005 | 1 | |
| 18 | 2024 | 0 | |
| 19 | 2009 | 0 |
About E. Feldman
E. Feldman is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Organic Chemistry, having authored 19 papers that have together received 163 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Chronic Myeloid Leukemia Treatments (4 papers), Histone Deacetylase Inhibitors Research (3 papers), Multiple Myeloma Research and Treatments (3 papers), Acute Lymphoblastic Leukemia research (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Retinoids in leukemia and cellular processes (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Hematology (103 citations), Genetics (39 citations), Public Health, Environmental and Occupational Health (58 citations), Oncology (41 citations) and Pathology and Forensic Medicine (22 citations). E. Feldman has collaborated with scholars based in United States and India. Frequent co-authors include Karen Seiter, Joseph Bertino, Ellin Berman, P. Maslak, David A. Scheinberg, David W. Golde, Toby Gee, Abraham Mittelman, Robert Knight and Peter L. Greenberg. Their work appears in journals such as Journal of Clinical Oncology, Bone Marrow Transplantation, Cancer Investigation, International Journal of Oncology and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.